KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Short term Debt: 2024

Historic Short term Debt for Adaptive Biotechnologies (ADPT) over the last 1 years, with Dec 2024 value amounting to $865,000.

  • Adaptive Biotechnologies' Short term Debt was N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $865,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Adaptive Biotechnologies' Short term Debt stood at $865,000.
  • In the past 5 years, Adaptive Biotechnologies' Short term Debt registered a high of $865,000 during FY2024, and its lowest value of $865,000 during FY2024.
  • Moreover, its 1-year median value for Short term Debt was $865,000 (2024), whereas its average is $865,000.